CIM Investment Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $511K | Buy |
67,113
+33,681
| +101% | +$256K | 0.1% | 175 |
|
|
2025
Q1 | $273K | Sell |
33,432
-801
| -2% | -$6.54K | 0.06% | 192 |
|
|
2024
Q4 | $322K | Buy |
34,233
+18,270
| +114% | +$172K | 0.09% | 183 |
|
|
2024
Q3 | $170K | Hold |
15,963
| – | – | 0.05% | 236 |
|
|
2024
Q2 | $158K | Sell |
15,963
-3,799
| -19% | -$37.7K | 0.05% | 233 |
|
|
2024
Q1 | $233K | Hold |
19,762
| – | – | 0.07% | 238 |
|
|
2023
Q4 | $280K | Hold |
19,762
| – | – | 0.09% | 212 |
|
|
2023
Q3 | $240K | Hold |
19,762
| – | – | 0.09% | 221 |
|
|
2023
Q2 | $248K | Hold |
19,762
| – | – | 0.08% | 221 |
|
|
2023
Q1 | $219K | Buy |
19,762
+680
| +4% | +$7.54K | 0.08% | 233 |
|
|
2022
Q4 | $233K | Hold |
19,082
| – | – | 0.09% | 203 |
|
|
2022
Q3 | $199K | Hold |
19,082
| – | – | 0.09% | 202 |
|
|
2022
Q2 | $205K | Hold |
19,082
| – | – | 0.09% | 204 |
|
|
2022
Q1 | $181K | Sell |
19,082
-2,222
| -10% | -$21.1K | 0.06% | 238 |
|
|
2021
Q4 | $246K | Hold |
21,304
| – | – | 0.07% | 245 |
|
|
2021
Q3 | $203K | Hold |
21,304
| – | – | 0.06% | 286 |
|
|
2021
Q2 | $205K | Hold |
21,304
| – | – | 0.06% | 287 |
|
|
2021
Q1 | $210K | Buy |
21,304
+11,567
| +119% | +$114K | 0.07% | 284 |
|
|
2020
Q4 | $225K | Sell |
9,737
-9,742
| -50% | -$225K | 0.07% | 253 |
|
|
2020
Q3 | $275K | Buy |
19,479
+281
| +1% | +$3.97K | 0.1% | 181 |
|
|
2020
Q2 | $290K | Sell |
19,198
-2,044
| -10% | -$30.9K | 0.12% | 172 |
|
|
2020
Q1 | $196K | Sell |
21,242
-20,000
| -48% | -$185K | 0.1% | 167 |
|
|
2019
Q4 | $402K | Buy |
+41,242
| New | +$402K | 0.16% | 135 |
|